Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angiodynamics Inc
(NQ:
ANGO
)
7.610
+0.150 (+2.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angiodynamics Inc
< Previous
1
2
3
4
5
6
7
Next >
AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022
December 15, 2021
From
AngioDynamics, Inc.
Via
Business Wire
Is This Under-the-Radar Medical Devices Stock a Buy?
November 03, 2021
The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?
Via
The Motley Fool
10 Biggest Price Target Changes For Friday
October 15, 2021
Cowen & Co. lowered the price target on Domino's Pizza, Inc. (NYSE:
Via
Benzinga
Mid-Afternoon Market Update: Gold Rises 2%; Bed Bath & Beyond Shares Slide
September 30, 2021
Toward the end of trading Thursday, the Dow traded down 0.74% to 34,136.80 while the NASDAQ rose 0.36% to 14,565.16. The S&P also fell, dropping 0.25% to 4,348.69. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
51 Biggest Movers From Friday
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
Investors Cheer AngioDynamics' Q1 Beat, Raised FY22 Sales Outlook
September 30, 2021
AngioDynamics Inc (NASDAQ: ANGO) reported a Q1 FY22 adjusted EPS loss of $(0.02), ahead of the consensus of $(0.04). Q1 sales increased 9.6% Y/Y to $77...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021
October 15, 2021
Upgrades B of A Securities upgraded the previous rating for WEC Energy Group Inc (NYSE:
Via
Benzinga
Mid-Day Market Update: Dow Drops Over 300 Points; Virgin Galactic Shares Jump
September 30, 2021
Midway through trading Thursday, the Dow traded down 0.97% to 34,056.76 while the NASDAQ fell 0.09% to 14,499.45. The S&P also fell, dropping 0.58% to 4,334.04. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
51 Biggest Movers From Yesterday
October 01, 2021
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
September 30, 2021
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5...
Via
Benzinga
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
September 30, 2021
ANGO earnings call for the period ending August 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Mid-Morning Market Update: Markets Mixed; CarMax Profit Misses Views
September 30, 2021
Following the market opening Thursday, the Dow traded down 0.11% to 34,352.56 while the NASDAQ climbed 0.44% to 14,576.37. The S&P also rose, gaining 0.15% to 4,365.81. The U....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
September 30, 2021
From
AngioDynamics, Inc.
Via
Business Wire
Earnings Scheduled For September 30, 2021
September 30, 2021
Companies Reporting Before The Bell • Antelope Enterprise Hldgs (NASDAQ:AEHL) is likely to report earnings for its first quarter. • Paychex (NASDAQ:PAYX) is...
Via
Benzinga
AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
September 15, 2021
From
AngioDynamics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021
August 20, 2021
Upgrades For Investors Bancorp Inc (NASDAQ:
Via
Benzinga
AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference
July 29, 2021
From
AngioDynamics, Inc.
Via
Business Wire
After Beating Estimates, Is This Little-Known Medical Device Company a Buy?
July 18, 2021
AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?
Via
The Motley Fool
Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript
July 13, 2021
ANGO earnings call for the period ending May 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AngioDynamics Breaks-Even In FY21, Issues Mixed Forecasts For FY22
July 13, 2021
AngioDynamics Inc (NASDAQ: ANGO) reports break-even in 4Q of 2021 with adjusted EPS of $0.00, a turnaround from EPS of (0.06) posted a year ago. The Company...
Via
Benzinga
AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
July 13, 2021
From
AngioDynamics, Inc.
Via
Business Wire
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
July 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...
Via
Benzinga
Earnings Scheduled For July 13, 2021
July 13, 2021
Companies Reporting Before The Bell • OrganiGram Holdings (NASDAQ:OGI) is estimated to report quarterly loss at $0.03 per share on revenue of $13.95 million. •...
Via
Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
July 11, 2021
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...
Via
Benzinga
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021
July 08, 2021
From
AngioDynamics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
June 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
June 24, 2021
From
AngioDynamics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.